Halobetasol Propionate
Product Images NDC 52959-961

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Halobetasol Propionate (NDC 52959-961). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H.j. Harkins Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (651e4050 Bc06 4037 Aea1 E38cd9f95b32 01)

Structural Formula (651e4050 Bc06 4037 Aea1 E38cd9f95b32 01)
Chemical structure of Halobetasol Propionate showing its steroid backbone with fluorine substituents, hydroxyl group, chlorinated ketone, and ethyl ester functional groups.*
FDA Label Image

Halobetasol Propionate Ointment, 0.05% Carton Image #1 (651e4050 Bc06 4037 Aea1 E38cd9f95b32 02)

Halobetasol Propionate Ointment, 0.05% Carton Image #1 (651e4050 Bc06 4037 Aea1 E38cd9f95b32 02)
Packaging label for Halobetasol Propionate 0.05% ointment by H.J. Harkins Company, Inc. The label shows NDC 52959-961-50, indicating a 50 gram ointment. It states lot number HPO50XV, manufactured by Perrigo PH in Israel, with an expiration date of 05/12. The label includes directions to follow physician instructions and references Ultravate as a comparison product with its NDC 45802-131-32.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.